Similar Frequencies of Pseudomonas aeruginosa Isolates Producing KPC and VIM Carbapenemases in Diverse Genetic Clones at Tertiary-Care Hospitals in Medellin, Colombia

A Systematic Review and Meta-Analyses Show that Carbapenem Use and Medical Devices Are the Leading Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa

(2014) A. F. Voor in 't holt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Caracterización de aislamientos de Pseudomonas aeruginosa productores de carbapenemasas de siete departamentos de Colombia

(2014) Sandra Yamile Saavedra et al.   Biomedica

Genome sequencing and characterization of an extensively drug-resistant sequence type 111 serotype O12 hospital outbreak strain of Pseudomonas aeruginosa

(2014) A.A. Witney et al.   CLINICAL MICROBIOLOGY AND INFECTION

Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea

(2014) Tark Kim et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Genotypic analysis of Pseudomonas aeruginosa isolated from ocular infection

(2014) Satoshi Yamaguchi et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Multilocus Sequence Typing Reveals Genetic Diversity of Carbapenem- or Ceftazidime-Nonsusceptible Pseudomonas aeruginosa in China

(2013) Jingshu Ji et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalencia de bacterias Gram negativas portadoras del gen blaKPC en hospitales de Colombia

(2013) Robinson Pacheco et al.   Biomedica

Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain

(2013) Margarita Gomila et al.   BMC MICROBIOLOGY

Isolation of NDM-1-producing Pseudomonas aeruginosa sequence type ST235 from a stem cell transplant patient in Italy, May 2013

(2013) A Carattoli et al.   Eurosurveillance

Selective advantages of two major clones of carbapenem-resistant Pseudomonas aeruginosa isolates (CC235 and CC641) from Korea: antimicrobial resistance, virulence and biofilm-forming activity

(2013) Ji-Young Lee et al.   JOURNAL OF MEDICAL MICROBIOLOGY

First Report of a Pseudomonas aeruginosa Isolate Coharboring KPC and VIM Carbapenemases

(2012) A. Correa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First clonal spread of KPC-producing Pseudomonas aeruginosa in Buenos Aires, Argentina

(2012) Gisela Santella et al.   INFECTION GENETICS AND EVOLUTION

OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea

(2012) Ji-Young Lee et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina

(2012) F. Pasteran et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Association of ertapenem and antipseudomonal carbapenem usage and carbapenem resistance in Pseudomonas aeruginosa among 12 hospitals in Queensland, Australia

(2012) D. A. J. McDougall et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa

(2012) A. Nakamura et al.   JOURNAL OF HOSPITAL INFECTION

Wide Dissemination of Pseudomonas aeruginosa Producing β-LactamaseblaKPC-2Gene in Colombia

(2011) Gaelle Cuzon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Detection of the KPC Gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-Based Nosocomial Surveillance Study in Puerto Rico

(2011) Iraida E. Robledo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multiplex PCR for detection of acquired carbapenemase genes

(2011) Laurent Poirel et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence

(2011) David P. Nicolau et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem

(2011) E. Riera et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Detección de un brote epidémico por Pseudomonas aeruginosa multirresistente productora de metalo-beta-lactamasa

(2011) A. Jimeno et al.   REVISTA CLINICA ESPANOLA

Emergence of KPC-Producing Pseudomonas aeruginosa in the United States

(2010) L. Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efflux Pumps, OprD Porin, AmpC  -Lactamase, and Multiresistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients

(2010) M. Tomas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey

(2010) Canan Kulah et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Emergence of KPC-Producing Pseudomonas aeruginosa in Trinidad and Tobago

(2009) P. E. Akpaka et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Carbapenem Resistance Mechanism and Risk Factors of Pseudomonas aeruginosa Clinical Isolates from a University Hospital in Xi'an, China

(2009) Jian-Fang Zhang et al.   Microbial Drug Resistance

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Imipenem-Resistant Pseudomonas aeruginosa : Risk Factors for Nosocomial Infections

(2008) Pinar Onguru et al.   JOURNAL OF KOREAN MEDICAL SCIENCE